The Venture Codex Logo

The Venture Codex

Yijing Capital

41F, Tower 2, Jing An Kerry Center 1539 West Nanjing Road, Shanghai, 200040, China

Overview

Investment company focused on medical and health-care sectors.

Founded

2015

Deals · 12mo

0

Links

Website

Stage focus

Series A
Series B
Series D

Geographic focus

Belgium
China
Switzerland
United States

Sector focus

Finance
Financial Services

Investment portfolio

6rounds
NAMEDATESIZE
Arnatar Therapeutics
Aug 2025Participated
$52 MSeries A
Phomera
Apr 2024Led
$14 MSeries A
Taichu Biotechnology
May 2023Participated
$57 MSeries A
Zhiketong Technology
Nov 2020Participated
$50 MSeries D
Etherna
Jun 2020Participated
$38 MSeries B
etherna immunotherapies
Jun 2020Participated
$38 MSeries B
Arnatar Therapeutics
Aug 2025Participated
$52 MSeries A
Phomera
Apr 2024Led
$14 MSeries A
Taichu Biotechnology
May 2023Participated
$57 MSeries A
Zhiketong Technology
Nov 2020Participated
$50 MSeries D
Etherna
Jun 2020Participated
$38 MSeries B
etherna immunotherapies
Jun 2020Participated
$38 MSeries B
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Yijing Capital: 6 funding rounds are recorded in the selected participation categories.All available history.
Yijing Capital: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A12
Series B02
Series C+01

Monthly Deal Activity

Yijing Capital: 6 deals are recorded across 77 months.All available history.
Yijing Capital: 6 deals are recorded across 77 months. All available history
MonthDeals
Jun '202
Jul '200
Aug '200
Sep '200
Oct '200
Nov '201
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '251
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Yijing Capital: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Yijing Capital: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Networks, Cloud & Communication2
Consumer & Lifestyle1
Marketing & Advertising1
Crypto & Blockchain1
Manufacturing1
Media & Entertainment1

Deal Size Distribution

Yijing Capital: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Yijing Capital: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M2
$50M-$100M3
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Yijing Capital: China has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Yijing Capital: China has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
China3
Europe2
United States1
Yijing Capital: 20 co-investors are shown, with BNP Paribas Fortis Private Equity sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Yijing Capital: 20 co-investors are shown, with BNP Paribas Fortis Private Equity sharing 2 recorded deals. All available history
Co-investorShared deals
BNP Paribas Fortis Private Equity2
EQT Life Sciences (LSP)2
Fund+2
Grand Decade2
Novalis LifeSciences2
Omega Funds2
PMV2
3E Bioventures Capital1
BASF Venture Capital1
Boehringer Ingelheim1
Boehringer Ingelheim Venture Fund1
Chuanhua Capital1
Eight Roads Ventures1
F-Prime Capital1
Gaorong Capital1
Hongsheng Capital1
IDG Capital1
Legend Star1
Longchenjia1
New Alliance Capital1

Investment Strategy

Yijing Capital: Led accounts for 17% and participating for 83% of round participation.All available history.
Yijing Capital: Led accounts for 17% and participating for 83% of round participation. All available history
CategoryDeals (count)Share (%)
Led117%
Participating583%
Yijing Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Yijing Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Jianqun Zhang

Chairman & Founder